Helicid Neo

Helicid Neo is an oral formulation that contains the proton pump inhibitor omeprazole as its active ingredient. It belongs to the gastrointestinal acid reducer class and is marketed in the European Union. The product works by irreversibly inhibiting the gastric H+/K+ ATPase, thereby reducing stomach acid production. Helicid Neo is used under medical supervision for conditions related to excess gastric acidity.

Helicid Neo is indicated for several acid‑related gastrointestinal conditions. It is commonly prescribed as part of a therapeutic regimen to manage the following:

- Gastro‑esophageal reflux disease (GERD) - Peptic ulcer disease, including duodenal and gastric ulcers - Prevention of NSAID‑induced gastric ulcers - Part of combination therapy for Helicobacter pylori eradication - Maintenance therapy to prevent ulcer recurrence after healing

Side effects of Helicid Neo vary in frequency and severity. Most patients experience mild, transient symptoms, while rare events may require medical attention.

Common: - Headache - Diarrhea or loose stools - Nausea or abdominal discomfort - Flatulence - Constipation - Dry mouth

Serious: - Severe allergic reactions (rash, swelling, difficulty breathing) - Clostridioides difficile‑associated colitis - Low magnesium levels (hypomagnesemia) - Liver enzyme elevations - Bone fractures with long‑term use

Before starting Helicid Neo, certain health considerations should be reviewed. Patients should discuss the following with their healthcare provider:

- History of liver disease or impaired hepatic function - Known hypersensitivity to omeprazole or other proton pump inhibitors - Existing low magnesium levels or risk factors for electrolyte imbalance - Use of long‑term therapy, especially in the elderly, due to fracture risk - Pregnancy or breastfeeding status, as safety data are limited - Concomitant use of medications that require an acidic environment for absorption

Helicid Neo can affect the pharmacokinetics of several other drugs. Awareness of these interactions helps to avoid reduced efficacy or increased toxicity.

Avoid: - Antiplatelet agents such as clopidogrel (reduced activation) - HIV protease inhibitors (e.g., atazanavir, nelfinavir) that need acidic pH for absorption - Certain antifungal agents (e.g., ketoconazole, itraconazole)

Use with caution: - Warfarin (potential increase in INR) - Digoxin (altered absorption) - Methotrexate (possible increased serum levels) - Diazepam and other benzodiazepines (enhanced effects)